Novavax booster dose option will be available at HCPH sites starting today!
Following approvals from the Centers for Disease Control and Prevention (CDC) and the Texas Department of State Health Services (DSHS), individuals 18 years and older who have completed their COVID-19 primary vaccine series will have the option to receive a COVID-19 Novavax monovalent booster vaccine instead of the updated (bivalent) Pfizer or Moderna booster vaccine at Harris County Public Health (HCPH) vaccination sites. Individuals who may not be able to receive an mRNA (Moderna or Pfizer) vaccine as a result of an allergy to a component of the vaccine will now have the Novavax booster as an option. The Novavax booster option will be available to eligible individuals regardless of their primary series vaccine type. The booster dose is recommended for individuals 6 months after they have completed their J&J, Moderna, Pfizer or Novavax primary vaccine series. The Novavax primary series first became available to the public in August so those who first received their Novavax primary series are not yet eligible for the Novavax booster dose. Individuals who would prefer the Novavax monovalent booster dose are encouraged to call 832-927-8787 for scheduling or visit any HCPH vaccination site to sign up. Novavax uses a different technique than the other COVID-19 vaccines from Pfizer and Moderna. Instead of using mRNA, which provides the instructions for your body to create the COVID-19 spike protein which in turn induces your body’s immune response, Novavax's vaccine injects a small protein that your body detects and triggers its immune response. The Novavax vaccine is based on a well-established method of vaccine development that has been used for years in other vaccines such as the human papillomavirus (HPV), hepatitis B, influenza, and shingles. COVID-19 primary and booster vaccines available at Harris County Public Health sites include:- Pfizer-BioNTech (mRNA vaccine)
- Moderna (mRNA vaccine)
- Novavax (protein subunit vaccine)




